Form 4 for SRPT Sarepta Therapeutics, Inc.

Accepted 2023-03-08 00:00:00 ET · period of report 2023-03-06 · accession 0001209191-23-017400 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-03-08	2023-03-06	SRPT	Brown Ryan Edward	SVP, GC	A - Grant	$0.00	+4,500	28.8K	+19%	$0
DM	2023-03-08	2023-03-06	SRPT	Brown Ryan Edward	SVP, GC	F - Tax	$157.21	-1,325	24.3K	-5%	-$208.3K
D	2023-03-08	2023-03-06	SRPT	Brown Ryan Edward	SVP, GC	A - Grant	$0.00	+27.0K	27.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-03-06	A	A	4,500	$0.00	28,820	D	—	—	(F3) The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date.
2	Common	Common Stock	2023-03-06	F	D	1,154	$157.21	24,491	D	—	—	(F1) Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021.
3	Common	Common Stock	2023-03-06	F	D	171	$157.21	24,320	D	—	—	(F2) Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 4, 2019.
4	Derivative	Stock Option (right to buy)	2023-03-06	A	A	27,000	$0.00	27,000	D	$155.99 · 2024-03-06 to 2033-03-06	27,000 Common Stock	(F4) Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.